Glenmark Pharmaceuticals (NSE:GLENMARK) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Glenmark Pharmaceuticals FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Glenmark Pharmaceuticals's Free Cash Flow for the three months ended in Dec. 2023 was ₹0 Mil. Glenmark Pharmaceuticals's Revenue for the three months ended in Dec. 2023 was ₹24,603 Mil. Therefore, Glenmark Pharmaceuticals's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, Glenmark Pharmaceuticals's current FCF Yield % is 0.06%.

The historical rank and industry rank for Glenmark Pharmaceuticals's FCF Margin % or its related term are showing as below:

NSE:GLENMARK' s FCF Margin % Range Over the Past 10 Years
Min: -7.4 Med: 1.76 Max: 8.05
Current: 0.13

During the past 13 years, the highest FCF Margin % of Glenmark Pharmaceuticals was 8.05%. The lowest was -7.40%. And the median was 1.76%.

NSE:GLENMARK's FCF Margin % is ranked better than
51.85% of 1026 companies
in the Drug Manufacturers industry
Industry Median: -0.675 vs NSE:GLENMARK: 0.13

Glenmark Pharmaceuticals FCF Margin % Historical Data

The historical data trend for Glenmark Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glenmark Pharmaceuticals FCF Margin % Chart

Glenmark Pharmaceuticals Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

FCF Margin %

Get a 7-Day Free Trial

0.90

4.43

3.30

2.62

0.14

Glenmark Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Glenmark Pharmaceuticals's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Glenmark Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Glenmark Pharmaceuticals's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Glenmark Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Glenmark Pharmaceuticals's FCF Margin % falls into.

Glenmark Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Glenmark Pharmaceuticals's FCF Margin for the fiscal year that ended in Mar. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2023 )	/	Revenue (A: Mar. 2023 )
	=	176.29	/	127254.33
	=	0.14 %

Glenmark Pharmaceuticals's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	0	/	24602.9
	=	0.00 %

Glenmark Pharmaceuticals FCF Margin % Related Terms

Thank you for viewing the detailed overview of Glenmark Pharmaceuticals's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Glenmark Pharmaceuticals (NSE:GLENMARK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Glenmark Pharmaceuticals Ltd (NSE:GLENMARK) » Definitions » FCF Margin %

Traded in Other Exchanges

532296:India

Address

Glenmark House, B. D. Sawant Marg, Chakala, Off Western Express Highway, Andheri (East), Mumbai, IND, 400099

Website

https://www.glenmarkpharma.com

Glenmark Pharmaceuticals Ltd is a specialty and generic drug manufacturing company. The company's research and development activity is focused on generating intellectual property assets that will help address unmet medical needs. Glenmark's product categories include novel molecular entities, formulations, and API products. The company considers merger and acquisition investment to be a potential component for expanding its research, development, manufacturing, and marketing capabilities.

Glenmark Pharmaceuticals (NSE:GLENMARK) Headlines

No Headlines